除了PD-L1之外,PD-L2在结直肠癌中充当一个独立的免疫检查点
Lvyun Zhu1, Ying Qu1, Junru Yang1
1Department of Biology and Chemistry, College of Sciences, National University of Defense Technology, Changsha, Hunan, China.
Frontiers in immunology
|December 17, 2024
概括
向PD-L2是一种新的策略,用于增强结直肠癌 (CRC) 的免疫治疗. 这种方法通过改善免疫细胞透和抗原呈现来补充PD-1/PD-L1阻塞,可能克服对当前治疗的耐药性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 免疫检查点封锁 (ICB) 对结直肠癌 (CRC) 治疗有希望.
- PD-1/PD-L1通路在瘤免疫抑制中至关重要,但许多CRC患者表现出有限的反应.
- 在CRC中对ICB的抵抗机制尚未完全理解.
研究的目的:
- 研究PD-L2作为结直肠癌治疗点的作用.
- 探索PD-L2与PD-1/PD-L1阻断结合,增强抗瘤免疫力的潜力.
主要方法:
- 在ICB研究中使用C57BL/6小鼠和MC38细胞系进行了实验.
- 基因和蛋白质表达分析使用qPCR,西布洛特和流细胞计进行.
- 生物信息学分析用于临床数据生存.
主要成果:
- 针对PD-L2提供了一个对CRC中PD-1/PD-L1封锁的补充策略.
- PD-L2在瘤微环境中表现出独特的空间分布,这表明不同的免疫逃避作用.
- PD-L1和PD-L2表达与免疫细胞透相关,包括树突细胞亚型,表明增强的抗原呈现.
结论:
- 在CRC中,PD-L2是一个重要的免疫检查点,类似于PD-L1.
- 准PD-L2有可能提高结肠直肠癌患者的抗瘤免疫力.
相关概念视频
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...